home / stock / frln / frln news

FRLN News and Press, Freeline Therapeutics Holdings plc From 09/28/20

Stock Information
Company Name: Freeline Therapeutics Holdings plc
Stock Symbol: FRLN
Market: NASDAQ
Website: freeline.life
Menu
FRLN FRLN Quote FRLN Short FRLN News FRLN Articles FRLN Message Board
Get FRLN Alerts

News, Short Squeeze, Breakout and More Instantly...
FRLN - Freeline announces promotion of Romuald Corbau, Ph.D. to Chief Scientific Officer

LONDON, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully integrated, next generation, systemic, AAV-based gene therapy company with the ambition of transforming the lives o...
FRLN - Freeline to participate in Chardan's 4th Annual Genetic Medicines Conference

LONDON, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of...

FRLN - Freeline inks supply agreement with Thermo Fisher

Freeline Therapeutics Holdings (FRLN) announced its supply agreement with Thermo Fisher Scientific (TMO) +1.3% PM.This agreement secures dedicated production capacity and resources for Freeline from 2021 to 2027, inclusive enabling capacity for the planned Phase 2b/3 pivotal clinica...

FRLN - Freeline announces supply agreement for haemophilia B program

LONDON, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical stage, fully-integrated, next generation, systemic, AAV-based gene therapy company with the ambition of transforming the lives o...
FRLN - Freeline Therapeutics Holdings (FRLN) Investor Presentation - Slideshow

The following slide deck was published by Freeline Therapeutics Holdings plc in conjunction with this Read more ...

FRLN - Freeline to participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference

LONDON, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of...

Previous 10 Next 10